Death during coronary angiography in a woman with cardiac amyloidosis.
Amyloidosis is a well-recognized systemic disease entity. Patients with cardiac amyloidosis have a poor prognosis; the median survival time after development of congestive heart failure is 4 months. We describe a 72-year-old woman with unsuspected cardiac amyloidosis who died during diagnostic coronary angiography. To our knowledge, this is the first report of this complication.
Anakwenze
Okechukwu A
OA
Mayo Medical School, Mayo Clinic College of Medicine, MN 55905, USA.
Lerman
Amir
A
Edwards
William D
WD
Gertz
Morie A
MA
Rihal
Charanjit S
CS
D000368:Aged; D000686:Amyloidosis / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D009202:Cardiomyopathies / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D017023:Coronary Angiography / Q000009:adverse effects; D003324:Coronary Artery Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D017809:Fatal Outcome; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology*; D006801:Humans